Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2735]

Novel way for scientists to predict chemotherapy resistance in ovarian cancer patients

Novel way for scientists to predict chemotherapy resistance in ovarian cancer patients

ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit

ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit

How 'paralysed' immune cells can be reactivated against brain tumours

How 'paralysed' immune cells can be reactivated against brain tumours

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients

Predicting chemotherapy response and tailoring treatments for pancreatic cancer patients

FDA approves nivolumab for resected oesophageal or GEJ cancer

FDA approves nivolumab for resected oesophageal or GEJ cancer

ASCO 2021: PET scans following initial treatment help many patients with bulky early-stage Hodgkin lymphoma avoid radiotherapy

ASCO 2021: PET scans following initial treatment help many patients with bulky early-stage Hodgkin lymphoma avoid...

Targeting abnormal cell metabolism shows promise for treating paediatric brain tumours

Targeting abnormal cell metabolism shows promise for treating paediatric brain tumours

Combination therapy achieves high rates of response for patients with ALL

Combination therapy achieves high rates of response for patients with ALL

Turning a pancreatic cancer cell's addiction into a death sentence

Turning a pancreatic cancer cell's addiction into a death sentence

PARP inhibitor shrinks tumours in pancreatic cancer patients with mutations

PARP inhibitor shrinks tumours in pancreatic cancer patients with mutations

More from ecancer